Discovery and verification of extracellular microRNA biomarkers for diagnostic and prognostic assessment of preeclampsia at triage
Science Advances · 22.12.2023 · 9 (51)
DOI: 10.1126/sciadv.adg7545 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 22.12.2023. Verfasst von Robert Morey und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynecology and Reproductive Medicine, University of California, San Diego, La Jolla, CA, USA. Hauptthemen laut MEDLINE: MicroRNAs, Pre-Eclampsia. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NICHD NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
We report on the identification of extracellular miRNA (ex-miRNA) biomarkers for early diagnosis and prognosis of preeclampsia (PE). Small RNA sequencing of maternal serum prospectively collected from participants undergoing evaluation for suspected PE revealed distinct patterns of ex-miRNA expression among different categories of hypertensive disorders in pregnancy. Applying an iterative machine learning method identified three bivariate miRNA biomarkers ( miR-522-3p/miR-4732-5p , miR-516a-5p/miR-144-3p , and miR-27b-3p/let-7b-5p ) that, when applied serially, distinguished between PE cases of different severity and differentiated cases from controls with a sensitivity of 93%, specificity of 79%, positive predictive value (PPV) of 55%, and negative predictive value (NPV) of 89%. In a small independent validation cohort, these ex-miRNA biomarkers had a sensitivity of 91% and specificity of 57%. Combining these ex-miRNA biomarkers with the established sFlt1:PlGF protein biomarker ratio performed better than either set of biomarkers alone (sensitivity of 89.4%, specificity of 91.3%, PPV of 95.5%, and NPV of 80.8%).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, Gynecology and Reproductive Medicine, University of California, San Diego, La Jolla, CA, USA.
- Department of Pathology, University of California, San Diego, La Jolla, CA, USA.
ORCID-Profile: Robert Morey, Lara Poling, Carolina Martinez-King, Kathy Zhang-Rutledge, Abbas Hakim, Kajal Verma, Morgan Meads, Mariko Horii, Gladys A Ramos, Peter DeHoff, Louise C Laurent
Förderung
- NIGMS NIH HHS
- NICHD NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Morey, R., Poling, L., Srinivasan, S., Martinez-King, C., Anyikam, A., Zhang-Rutledge, K., To, C., Hakim, A., Mochizuki, M., Verma, K., Mason, A., Tran, V., Meads, M., Lamale-Smith, L., Roeder, H., Horii, M., Ramos, G. A., DeHoff, P., Parast, M. M., …, & Laurent, L. C. (2023). Discovery and verification of extracellular microRNA biomarkers for diagnostic and prognostic assessment of preeclampsia at triage. Science Advances, 9(51). https://doi.org/10.1126/sciadv.adg7545
Vancouver
Morey R, Poling L, Srinivasan S, Martinez-King C, Anyikam A, Zhang-Rutledge K, et al. Discovery and verification of extracellular microRNA biomarkers for diagnostic and prognostic assessment of preeclampsia at triage. Science Advances. 2023;9(51). doi:10.1126/sciadv.adg7545
BibTeX
@article{Morey2023,
author = {Morey, Robert and Poling, Lara and Srinivasan, Srimeenakshi and Martinez-King, Carolina and Anyikam, Adanna and Zhang-Rutledge, Kathy and To, Cuong and Hakim, Abbas and Mochizuki, Marina and Verma, Kajal and Mason, Antoinette and Tran, Vy and Meads, Morgan and Lamale-Smith, Leah and Roeder, Hilary and Horii, Mariko and Ramos, Gladys A and DeHoff, Peter and Parast, Mana M and Pantham, Priyadarshini and Laurent, Louise C},
title = {Discovery and verification of extracellular microRNA biomarkers for diagnostic and prognostic assessment of preeclampsia at triage},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {51},
doi = {10.1126/sciadv.adg7545}
}
EUVIMED